Stevens-Johnson syndrome (SJS), also called erythema multiforme major, is a systemic disease mostly involving the skin and mucous membranes. The cutaneous lesions are those of erythema multiforme ...

A NUMBER of reports have appeared in the literature in recent years on the condition known as the Stevens-Johnson syndrome. The numerous descriptive names attached to its multiple manifestations ...

What the government refers to as “Anomalous Health Incidents,” Havana syndrome has afflicted hundreds ... that Turner was removed as a result of Johnson’s deference to President-elect ...

Former Patriots linebacker Ted Johnson is joining the station to co-host “WEEI Afternoons” from 2-6 alongside Andy Hart and Nick “Fitzy” Stevens, who is expanding his role. Christian ...

Pittsburgh Steelers on SI publisher Noah Strackbein offered this when asked if he would sign Johnson: "From the time Diontae Johnson left Pittsburgh to today, the journey has been wild.

Johnson & Johnson (NYSE:JNJ) has had a rough three months with its share price down 11%. However, stock prices are usually driven by a company’s financials over the long term, which in this case ...

On Friday, the CFL club announced a contract extension for Johnson, a four-time CFL all-star ... so make sure to bookmark leaderpost.com and sign up for our newsletters so we can keep you informed.

Ben Johnson is expected to travel to Chicago Tuesday morning at which point he will sign a contract to become the next coach of the #Bears. — Brad Biggs (@BradBiggs) January 20, 2025 Ben Johnson ...

Tributes quickly began pouring in from fans and colleagues, including fellow director Steven Spielberg, who cast Lynch in his 2022 film "The Fabelmans." Lynch portrayed director John Ford ...

Gabby Jones / Bloomberg / Getty Images Johnson & Johnson is scheduled to report fourth-quarter earnings Wednesday morning, with analysts expecting sales and profits to grow year-over-year.

Johnson & Johnson (NYSE:JNJ) is scheduled to announce Q4 earnings results on Wednesday, January 22nd, before market open. Analysts expect a profit per share of $2.02, which is a decline of 11.8% ...

Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged him and caused infections. Johnson experienced ...